[NICE Consultation] Osimertinib for untreated EGFR-positive non-small-cell lung cancer [ID1302]

NICE |  April 2019 | Osimertinib for untreated EGFR-positive non-small-cell lung cancer [ID1302]

The NICE consultation on Osimertinib for untreated EGFR-positive non-small-cell lung cancer [ID1302] is open until 9 May 2019 

Full details from NICE 

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s